HEADER HYDROLASE 08-SEP-05 2C0Y TITLE THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN S COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCATHEPSIN S; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROENZYME, RESIDUES 17-331; COMPND 5 EC: 3.4.22.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: TESTIS; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PROCATHEPSIN S, PROENZYME, PROTEINASE, HYDROLASE, THIOL PROTEASE, KEYWDS 2 PROSEGMENT BINDING LOOP, GLYCOPROTEIN, LYSOSOME, PROTEASE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR G.KAULMANN,G.J.PALM,K.SCHILLING,R.HILGENFELD,B.WIEDERANDERS REVDAT 6 13-DEC-23 2C0Y 1 REMARK REVDAT 5 24-JUL-19 2C0Y 1 REMARK REVDAT 4 29-MAY-19 2C0Y 1 REMARK REVDAT 3 03-APR-19 2C0Y 1 SOURCE REVDAT 2 24-FEB-09 2C0Y 1 VERSN REVDAT 1 08-NOV-06 2C0Y 0 JRNL AUTH G.KAULMANN,G.J.PALM,K.SCHILLING,R.HILGENFELD,B.WIEDERANDERS JRNL TITL THE CRYSTAL STRUCTURE OF A CYS25 -> ALA MUTANT OF HUMAN JRNL TITL 2 PROCATHEPSIN S ELUCIDATES ENZYME-PROSEQUENCE INTERACTIONS. JRNL REF PROTEIN SCI. V. 15 2619 2006 JRNL REFN ISSN 0961-8368 JRNL PMID 17075137 JRNL DOI 10.1110/PS.062401806 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.E.MCGRATH,J.T.PALMER,D.BROMME,J.R.SOMOZA REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN CATHEPSIN S REMARK 1 REF PROTEIN SCI. V. 7 1294 1998 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 9655332 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.P.TURKENBURG,M.B.LAMERS,A.M.BRZOZOWSKI,L.M.WRIGHT, REMARK 1 AUTH 2 R.E.HUBBARD,S.L.STURT,D.H.WILLIAMS REMARK 1 TITL STRUCTURE OF A CYS25 TO SER MUTANT OF HUMAN CATHEPSIN S REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 451 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 11856830 REMARK 1 DOI 10.1107/S0907444901021825 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.A.PAULY,T.SULEA,M.AMMIRATI,J.SIVARAMAN,D.E.DANLEY, REMARK 1 AUTH 2 M.C.GRIFFOR,A.V.KAMATH,I.K.WANG,E.R.LAIRD,A.P.SEDDON, REMARK 1 AUTH 3 R.MENARD,M.CYGLER,V.L.RATH REMARK 1 TITL SPECIFICITY DETERMINANTS OF HUMAN CATHEPSIN S REVEALED BY REMARK 1 TITL 2 CRYSTAL STRUCTURES OF COMPLEXES REMARK 1 REF BIOCHEMISTRY V. 42 3203 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12641451 REMARK 1 DOI 10.1021/BI027308I REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1874964.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 19350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 972 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.14 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1691 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 87 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2459 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.48000 REMARK 3 B33 (A**2) : 0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.770 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.530 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.900 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.920 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 62.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2C0Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1290025086. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.803 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : TRIANGULAR SI (111) REMARK 200 MONOCHROMATOR AND A CONTINUOUS REMARK 200 BENT RH-COATED MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19350 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1BY8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLISATION WAS PERFORMED BY THE REMARK 280 HANGING-DROP VAPOUR DIFFUSION METHOD. EQUAL VOLUMES PROCATHEPSIN REMARK 280 S (CYS25ALA) AT 7.0 MG/ML AND WELL SOLUTION WERE COMBINED AND REMARK 280 PLACED OVER A WELL CONTAINING 0.1M TRIS/HCL, 0.2M MAGNESIUM REMARK 280 ACETATE AND 20% PEG 8000, PH 7.5, PH 7.50, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.30500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.30500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.93000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.27000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.93000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.27000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 39.30500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.93000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 70.27000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 39.30500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.93000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 70.27000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2053 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 PROTEASE RESPONSIBLE FOR THE REMOVAL OF THE INVARIANT CHAIN REMARK 400 FROM MHC CLASS II MOLECULES REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 139 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 2 REMARK 465 LYS A 93 REMARK 465 SER A 94 REMARK 465 ASN A 95 REMARK 465 PRO A 96 REMARK 465 ASN A 97 REMARK 465 ARG A 98 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 28 -5.85 75.53 REMARK 500 ASN A 63 -167.27 -78.93 REMARK 500 ARG A 81 71.81 -105.75 REMARK 500 THR A 91 -98.86 -123.62 REMARK 500 SER A 120 40.20 -97.15 REMARK 500 THR A 157 -135.45 -105.35 REMARK 500 ARG A 240 53.01 -66.52 REMARK 500 ASN A 262 -1.21 -150.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2075 DISTANCE = 6.76 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BXF RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURES OF THE CYSTEINE- PROTEASES CATHEPSINS REMARK 900 K AND S DEDUCED BY KNOWLEDGE-BASED MODELLING AND ACTIVE-SITE REMARK 900 CHARACTERISTICS REMARK 900 RELATED ID: 1GLO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S REMARK 900 RELATED ID: 1MS6 RELATED DB: PDB REMARK 900 DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S. REMARK 900 RELATED ID: 1NPZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES REMARK 900 RELATED ID: 1NQC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES REMARK 999 REMARK 999 SEQUENCE REMARK 999 CLONED WITHOUT SIGNAL PEPTIDE DBREF 2C0Y A 2 316 UNP P25774 CATS_HUMAN 17 331 SEQADV 2C0Y ALA A 124 UNP P25774 CYS 139 ENGINEERED MUTATION SEQADV 2C0Y SER A 146 UNP P25774 THR 161 VARIANT SEQRES 1 A 315 GLN LEU HIS LYS ASP PRO THR LEU ASP HIS HIS TRP HIS SEQRES 2 A 315 LEU TRP LYS LYS THR TYR GLY LYS GLN TYR LYS GLU LYS SEQRES 3 A 315 ASN GLU GLU ALA VAL ARG ARG LEU ILE TRP GLU LYS ASN SEQRES 4 A 315 LEU LYS PHE VAL MET LEU HIS ASN LEU GLU HIS SER MET SEQRES 5 A 315 GLY MET HIS SER TYR ASP LEU GLY MET ASN HIS LEU GLY SEQRES 6 A 315 ASP MET THR SER GLU GLU VAL MET SER LEU MET SER SER SEQRES 7 A 315 LEU ARG VAL PRO SER GLN TRP GLN ARG ASN ILE THR TYR SEQRES 8 A 315 LYS SER ASN PRO ASN ARG ILE LEU PRO ASP SER VAL ASP SEQRES 9 A 315 TRP ARG GLU LYS GLY CYS VAL THR GLU VAL LYS TYR GLN SEQRES 10 A 315 GLY SER CYS GLY ALA ALA TRP ALA PHE SER ALA VAL GLY SEQRES 11 A 315 ALA LEU GLU ALA GLN LEU LYS LEU LYS THR GLY LYS LEU SEQRES 12 A 315 VAL SER LEU SER ALA GLN ASN LEU VAL ASP CYS SER THR SEQRES 13 A 315 GLU LYS TYR GLY ASN LYS GLY CYS ASN GLY GLY PHE MET SEQRES 14 A 315 THR THR ALA PHE GLN TYR ILE ILE ASP ASN LYS GLY ILE SEQRES 15 A 315 ASP SER ASP ALA SER TYR PRO TYR LYS ALA MET ASP GLN SEQRES 16 A 315 LYS CYS GLN TYR ASP SER LYS TYR ARG ALA ALA THR CYS SEQRES 17 A 315 SER LYS TYR THR GLU LEU PRO TYR GLY ARG GLU ASP VAL SEQRES 18 A 315 LEU LYS GLU ALA VAL ALA ASN LYS GLY PRO VAL SER VAL SEQRES 19 A 315 GLY VAL ASP ALA ARG HIS PRO SER PHE PHE LEU TYR ARG SEQRES 20 A 315 SER GLY VAL TYR TYR GLU PRO SER CYS THR GLN ASN VAL SEQRES 21 A 315 ASN HIS GLY VAL LEU VAL VAL GLY TYR GLY ASP LEU ASN SEQRES 22 A 315 GLY LYS GLU TYR TRP LEU VAL LYS ASN SER TRP GLY HIS SEQRES 23 A 315 ASN PHE GLY GLU GLU GLY TYR ILE ARG MET ALA ARG ASN SEQRES 24 A 315 LYS GLY ASN HIS CYS GLY ILE ALA SER PHE PRO SER TYR SEQRES 25 A 315 PRO GLU ILE FORMUL 2 HOH *242(H2 O) HELIX 1 1 ASP A 6 THR A 8 5 3 HELIX 2 2 LEU A 9 GLY A 21 1 13 HELIX 3 3 ASN A 28 MET A 53 1 26 HELIX 4 4 ASN A 63 MET A 68 5 6 HELIX 5 5 THR A 69 MET A 77 1 9 HELIX 6 6 SER A 84 ARG A 88 5 5 HELIX 7 7 ALA A 123 GLY A 142 1 20 HELIX 8 8 SER A 148 SER A 156 1 9 HELIX 9 9 THR A 157 GLY A 161 5 5 HELIX 10 10 LYS A 163 GLY A 167 5 5 HELIX 11 11 PHE A 169 LYS A 181 1 13 HELIX 12 12 ASP A 201 LYS A 203 5 3 HELIX 13 13 ARG A 219 LYS A 230 1 12 HELIX 14 14 HIS A 241 LEU A 246 1 6 HELIX 15 15 ASN A 303 ILE A 307 5 5 SHEET 1 AA 6 TYR A 58 LEU A 60 0 SHEET 2 AA 6 TYR A 247 TYR A 252 -1 N ARG A 248 O ASP A 59 SHEET 3 AA 6 TYR A 294 ALA A 298 1 O ARG A 296 N TYR A 252 SHEET 4 AA 6 LYS A 276 LYS A 282 -1 O TRP A 279 N MET A 297 SHEET 5 AA 6 HIS A 263 LEU A 273 -1 O LEU A 266 N LYS A 282 SHEET 6 AA 6 VAL A 104 ASP A 105 -1 O VAL A 104 N TYR A 270 SHEET 1 AB 6 TYR A 58 LEU A 60 0 SHEET 2 AB 6 TYR A 247 TYR A 252 -1 N ARG A 248 O ASP A 59 SHEET 3 AB 6 TYR A 294 ALA A 298 1 O ARG A 296 N TYR A 252 SHEET 4 AB 6 LYS A 276 LYS A 282 -1 O TRP A 279 N MET A 297 SHEET 5 AB 6 HIS A 263 LEU A 273 -1 O LEU A 266 N LYS A 282 SHEET 6 AB 6 VAL A 233 VAL A 237 -1 O VAL A 233 N VAL A 267 SHEET 1 AC 2 ILE A 183 ASP A 184 0 SHEET 2 AC 2 ARG A 205 ALA A 207 -1 N ALA A 206 O ILE A 183 SHEET 1 AD 2 LYS A 211 GLU A 214 0 SHEET 2 AD 2 SER A 312 GLU A 315 -1 O TYR A 313 N THR A 213 SSBOND 1 CYS A 121 CYS A 165 1555 1555 2.04 SSBOND 2 CYS A 155 CYS A 198 1555 1555 2.04 SSBOND 3 CYS A 257 CYS A 305 1555 1555 2.04 CRYST1 59.860 140.540 78.610 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016706 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007115 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012721 0.00000